Sientra’s shares nosedived more than 52 percent on Sept. 24 and several law firms around the country announced on Sept. 25 investigations into possible violations of federal securities laws. On Sept. 23, the Goleta-based breast implant manufacturer sold 3 million new shares in a public offering. The offering raised $66 million for the company before Read More →
For most small businesses, the toughest aspect of running the operation is managing cash flow. Most small businesses depend on timely payments from their clients to pay their own bills. However, in difficult times such as these, clients often stretch payment of their invoices to 60 days or longer. In order to be able to Read More →
An experimental multiple myeloma treatment using Amgen’s Kyprolis will get an expedited review from the U.S. Food and Drug Administration. The FDA said it will use an expedited review process to review a multiple-myeloma treatment using Kyprolis and the genric drug dexamethasone. On July 23, Amgen submitted additional data to the FDA which compared this Read More →
A new Central Coast tech venture capital fund will give entrepreneurs in the Highway 101 corridor another avenue for funding. Santa Barbara Technology Ventures seeks to invest primarily in tech startups by having a close affiliation with companies coming out of UC Santa Barbara and Cal Poly San Luis Obispo, according to a Sept. 1 Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Goleta-based Community West Bank opened a new loan production office in San Luis Obispo, the company announced Sept. 17. The bank snatched up area expertise when it hired Bill Filippin in May as the executive vice president. Filippin previously worked with San Luis Obispo-based Heritage Oaks Bank (and Mission Community Bank until it was merged Read More →
Thousand Oaks-based biopharmaceutical giant Amgen bought a Netherlands-based company and partnered with a Monrovia-based company in an effort to fend off competitors. Amgen announced Sept. 16 that it will buy Dezima, a biotech company focused on developing new treatments for dyslipidemia, a disease where a person has an abnormal amount of lipids in their blood. Read More →